Impact of Access Site on Periprocedural Bleeding and Cerebral and Coronary Events in High-Bleeding-Risk Percutaneous Coronary Intervention: Findings from the RIVA-PCI Trial
ConclusionsIn HBR patients with AF undergoing PCI for acute or chronic coronary syndrome, the use of TRA might be associated with a decrease in in-hospital bleeding, while not increasing the risk of embolic or ischemic events compared to femoral access. Further studies are required to confirm these preliminary findings.
Source: Cardiology and Therapy - Category: Cardiology Source Type: research
More News: Angioplasty | Atrial Fibrillation | Bleeding | Cardiology | Cardiovascular | Chronic Kidney Disease | Coronary Angioplasty | Heart | Heart Attack | Heart Failure | Hemorrhagic Stroke | Ischemic Stroke | Percutaneous Coronary Intervention | Stroke | Study | Thrombosis | Urology & Nephrology